Ampio Pharmaceuticals, Inc. (AMPE) Financials

AMPE Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 5.7 million 2.4 million
Sept. 30, 2023 7.6 million 2.3 million
June 30, 2023 9.1 million 2.6 million
March 31, 2023 10.7 million 2.9 million

AMPE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -2.3 million ?
Sept. 30, 2023 -555000 44000
June 30, 2023 -3.4 million 53000
March 31, 2023 -2.3 million 23000

AMPE Net Income

No data available :(

AMPE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 4.1 million - 274000
Sept. 30, 2023 6.4 million - 362000
June 30, 2023 7.0 million 94000 448000
March 31, 2023 10.4 million - 532000

AMPE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 ?
Sept. 30, 2023 804158
June 30, 2023 754697
March 31, 2023 754694

AMPE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - 1.2 million 973000 -
Sept. 30, 2023 - 329000 1.1 million -
June 30, 2023 - 344000 1.2 million -
March 31, 2023 - 524000 3.8 million -

AMPE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 245000 -
Sept. 30, 2023 - -
June 30, 2023 - -
March 31, 2023 - 245000

AMPE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AMPE

Price: $0.18

52 week price:
0.00
0.30

Earnings Per Share: -10.66 USD

P/E Ratio: -0.03

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 49694

Market Capitalization: 5904

Links: